A fermented food product containing lactic acid bacteria protects ZDF rats from the development of type 2 diabetes

Type 2 diabetes (T2D) is a complex metabolic disease, which involves a maintained hyperglycemia due to the development of an insulin resistance process. Among multiple risk factors, host intestinal microbiota has received increasing attention in T2D etiology and progression. In the present study, we...

ver descrição completa

Detalhes bibliográficos
Autores: Cabello Olmo, Miriam, Oneca Agurruza, María, Torre Hernández, Paloma, Sáinz, Neira, Moreno Aliaga, María J., Guruceaga, Elizabeth, Díaz, Jesús Vicente, Encío Martínez, Ignacio, Barajas Vélez, Miguel Ángel, Araña Ciordia, Miriam
Formato: artículo
Estado:Versión publicada
Fecha de publicación:2019
País:España
Recursos:Universidad Pública de Navarra
Repositorio:Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
OAI Identifier:oai:academica-e.unavarra.es:2454/36912
Acesso em linha:https://hdl.handle.net/2454/36912
Access Level:acceso abierto
Palavra-chave:Diabetes
Fermented food
Gut microbiota
Lactic acid bacteria
Postbiotic
Probiotic
Descrição
Resumo:Type 2 diabetes (T2D) is a complex metabolic disease, which involves a maintained hyperglycemia due to the development of an insulin resistance process. Among multiple risk factors, host intestinal microbiota has received increasing attention in T2D etiology and progression. In the present study, we have explored the effect of long-term supplementation with a non-dairy fermented food product (FFP) in Zucker Diabetic and Fatty (ZDF) rats T2D model. The supplementation with FFP induced an improvement in glucose homeostasis according to the results obtained from fasting blood glucose levels, glucose tolerance test, and pancreatic function. Importantly, a significantly reduced intestinal glucose absorption was found in the FFP-treated rats. Supplemented animals also showed a greater survival suggesting a better health status as a result of the FFP intake. Some dissimilarities have been observed in the gut microbiota population between control and FFP-treated rats, and interestingly a tendency for better cardiometabolic markers values was appreciated in this group. However, no significant differences were observed in body weight, body composition, or food intake between groups. These findings suggest that FFP induced gut microbiota modifications in ZDF rats that improved glucose metabolism and protected from T2D development.